Roche stock is falling after report its Wegovy challenger is causing patients to vomit
Positive results in the early stages of Roche's weight-loss pill development had given investors hope it could quickly catch up with rivals Novo Nordisk and Eli Lilly.
Tomas Kauer 
Positive results in the early stages of Roche's weight-loss pill development had given investors hope it could quickly catch up with rivals Novo Nordisk and Eli Lilly. Read More
